HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lei, B. Articles by Sieving, P. A. Search for Related Content PubMed PubMed Citation Articles by Lei, B. Articles by Sieving, P. A.

Human Melanoma-Associated Retinopathy (MAR) Antibodies Alter the Retinal ON-Response of the Monkey ERG In Vivo

¹ From the Department of Ophthalmology and Neuroscience Program, the W. K. Kellogg Eye Center, University of Michigan, Ann Arbor; and the ² Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, PA.

PURPOSE. Melanoma-associated retinopathy (MAR) is a paraneoplastic condition that causes visual symptoms of night-blindness and photopsias. The electroretinogram (ERG) of MAR patients is characteristically abnormal in a way that implicates retinal depolarizing bipolar cell (DBC) dysfunction. Whether an injection of IgG from MAR patients into the vitreous of monkeys would alter the ERG acutely as a demonstration of a functional basis for patients’ visual symptoms was explored.

METHODS. MAR IgG was isolated from three visually symptomatic melanoma patients. Control IgG was from melanoma patients with no vision problems. The ERG was monitored after intravitreal injections into monkey eyes. One eye was injected with 2-amino-4-phosphonobutyric acid (APB), which is known to block DBC ON-pathway responses. Retinal immunocytochemistry was performed using fluorescein isothiocyanate–labeled goat anti-human IgG.

RESULTS. Within 1 to 3 hours after MAR IgG injection, the ERG photopic b-wave was diminished, with far less effect on the a- and d-waves. These changes are characteristic of DBC dysfunction and were similar to the effects of APB. The scotopic ERG b-wave, which reflects activity of rod-driven DBCs, showed a loss of amplitude and threshold sensitivity after MAR IgG. Retinal immunocytochemistry with anti-IgG antibody showed IgG penetration throughout the retinal layers, but staining was not specific for a single type of retinal neuron.

CONCLUSIONS. Intravitreal injection of human MAR IgG altered the monkey ERG acutely in ways that implicate functional disruption of retinal DBC signaling. These results support the hypothesis that MAR IgG circulating antibodies are responsible for the reported visual symptoms. Bipolar cells in the ON-pathway appear to be affected more than OFF-pathway bipolar cells of the cone pathway in this acute preparation.

This article has been cited by other articles:

				P. Heiduschka, H. Fietz, S. Hofmeister, S. Schultheiss, A. F. Mack, S. Peters, F. Ziemssen, B. Niggemann, S. Julien, K. U. Bartz-Schmidt, et al. Penetration of Bevacizumab through the Retina after Intravitreal Injection in the Monkey Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2814 - 2823. [Abstract] [Full Text] [PDF]

				A G Robson, E C Richardson, A H C Koh, C E Pavesio, P G Hykin, A Calcagni, E M Graham, and G E Holder Unilateral electronegative ERG of non-vascular aetiology Br. J. Ophthalmol., December 1, 2005; 89(12): 1620 - 1626. [Abstract] [Full Text] [PDF]

				G E Holder, A G Robson, C Pavesio, and E M Graham Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy Br. J. Ophthalmol., June 1, 2005; 89(6): 709 - 718. [Abstract] [Full Text] [PDF]

				K. R. Alexander, C. S. Barnes, G. A. Fishman, J. Pokorny, and V. C. Smith Contrast-Processing Deficits in Melanoma-Associated Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 305 - 310. [Abstract] [Full Text] [PDF]

				A. M. Palmowski, A. H. Haus, C. Pfohler, U. Reinhold, R. Allgayer, W. Tilgen, K. W. Ruprecht, and C. E. Thirkill Bilateral Multifocal Chorioretinopathy in a Woman With Cutaneous Malignant Melanoma Arch Ophthalmol, December 1, 2002; 120(12): 1756 - 1761. [Full Text] [PDF]

				K. R. Alexander, C. S. Barnes, G. A. Fishman, and A. H. Milam Nature of the Cone ON-Pathway Dysfunction in Melanoma-Associated Retinopathy Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1189 - 1197. [Abstract] [Full Text] [PDF]

				J. J. Hooks, M. O. M. Tso, and B. Detrick Retinopathies Associated with Antiretinal Antibodies Clin. Vaccine Immunol., September 1, 2001; 8(5): 853 - 858. [Full Text] [PDF]